JR Precious, former Finance Director 1990-1994

Interviewee joined company in 1990 as Finance Director and left in 1994.

Pages 1-41 only of 47 are available. Pages 42-47 have been catalogued separately in WF/M/AV/O/02/50c and closed. Topics discussed include:

* impressions of company, and lengthy assessment of it

* corporate atmosphere

* effects of the flotation an changes within company

* research costs and management

* provision of financial information

* relationship between UK and US companies

* Retrovir, issues over pricing and marketing, public relations/ customer relations, Concorde Study

* Japan market

* Calmic, Wellcome Environmental Health, Wellcome Diagnostic

* relationship between WT and company

* potential merger with Zeneca

* share price and merger with Glaxo

Transcript

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.